Publications

Rios A, Brewton G, Crofoot G, Quesada J, Lenk R, and Lopez-Berenstein G. A phase I-II clinical study of Nystatin-LF IV in patients with HIV infections (abstract). IX International Conference on AIDS, Berlin, Germany, June 1993.

Hersh E, Brewton G, Abrams D, Bartlett J, Gallon J, Gill P, Gorter R, Gottlieb M, Jonikas J, Landesman S, Levine A, Marcel A, Petersen E, Whiteside M, Zahradnik J, Negron C, Boutitie F, Caraux J, Dupuy J, and Salmi R. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS: a randomized, double blind, placebo-controlled multi-center study. JAMA 1991; 265 (12): 1538-4.

Hersh E, Brewton G, Abrams D, Bartlett G, Gottlieb M, Landesman S, Leaven A, Whiteside M, Petersen E, Zahradnik J, Negron C, Dupuy J, Salmi R, and Carau J. A randomized, double blind, placebo controlled trial of diethyldithiocarbamate (ditiocarb, Imuthiol) in patients with ARC and AIDS (abstract). VI International Conference on AIDS, San Francisco, California, June 1990.

Brewton G, Hersh E, Rios A, Mansell P, Hollinger B, and Reuben J. A pilot study on diethyldithiocarbamate in patients with Acquired Immune Deficiency Syndrome (AIDS) and the AIDS-Related Complex. Life Sciences 1989; 45: 250:20.

Rolston K, Rodriguez S, Carvajal F, Nelson J, Brewton G, Rios A, Bodey G, and Mansell P. Therapy of cytomegalovirus (CMV) infections with ganciclovir (abstract). V International Conference on AIDS, Montreal, Canada, June 1989.

Hersh E. Petersen E, Yocum D, German S, Darragh M, Gschwind C, Brewton G, and Reuben J. Immunological characteristics and potential approaches to immunotherapy of HIV infection. Recent Results in Cancer Research 1988; 112: 17-26.

Reuben J, Liang Li, Rios A, Li S, Brewton G, Sarin P, and Mansell P. Polyclonal activation of B cells by HIV isolates is T Cell dependent (abstract). IV International Conference on AIDS, Stockholm, Sweden, June 1988.

Duvic M, Johnson T, Rapini R, Freese T, Brewton G, and Rios A. AIDS associated psoriasis and Reiter's syndrome. Archives of Dermatology 1987; 123: 1622-32.

Duvic M, Rios A, and Brewton G. Remission of AIDS associated psoriasis with zidovudine. Lancet 1967; 2(8559): 627.

Daiger S, Rios A, Brewton G, Mansell P, and Reuben J. Genetic susceptibility of AIDS: absence of an association with group-specific component (Gc) (letter). New England J Med 1987; 317: 631-2.

Brewton G, Hersh E, Mansell P, Rios A, and Reuben J. Use of Imuthiol (diethyldithiocarbamate, DTC) in symptomatic HIV infection (abstract). III International Conference on AIDS, Washington, D.C., June, 1987.

Reuben J, Rios A, Naylor P, Brewton G, Goldstein A, and Mansell P. Modulation of T cell proliferative responses by envelope and core antigens of the Human Immunodeficiency Virus (abstract). III International Conference on AIDS Washington, D.C., June 1987.

Reuben J, Rios A, Brewton G, and Mansell P. The generation of natural killer and lymphokine activated killer cells in HIV infected individuals (abstract). III International Conference on AIDS, Washington, D.C., June 1987.

Rios A, Reuben J, Brewton G, and Mansell P. Phase I study of the use of lymphoblastoid interferon HuIFN (Ly) and difluoromethylornithine (DFMO) in the treatment acquired immune deficiency syndrome (AIDS) related Kaposi's sarcoma (abstract). III International Conference on AIDS, Washington, D.C., June 1987.

Brewton G, Use of Imuthiol (diethyldithiocarbamate) in symptomatic HIV infection. In: Girard M, de The G, and Valette L (eds.) Retroviruses of Human AIDS and Related Animal Disease proceedings of "Colloque des Cent Gardes" symposium, October 2~3O, 1986, Marnes-La-Coquette/Paris, France, pp. 199-200.

Brewton G, Hersh E, Reuben J, Rios A, and Mansell P. Preliminary observations on Imuthiol therapy in symptomatic HTLV-IIIILAV infection (abstract). II International Conference on AIDS, Paris, France, June 1986.

Mansell P, Rolston K, Hoy J, Hernandez M, Rios A, Brewton G, and Buhles W. The treatment of cytomegalovirus infections in patients with acquired immune deficiency syndrome (AIDS) or following bone marrow transplantation with dihydroxypropoxymethylguanine (DHPG) (abstract). II International Conference on AIDS, Paris, France, June 1986.